steffanjoe101
0
Following
0
Follower
0
Boost
steffanjoe101

Progressive Supranuclear Palsy (PSP) Therapies Market

The exact cause of this rare disorder, which affects 5-17 in 100,000 people, is unknown; however, a complex interplay between different risk factors, including age, genetics and environment, is likely to contribute to the onset of this rare tauopathy London Roots Analysis has announced the addition of “Progressive Supranuclear Palsy Therapies Market, 2021-2030” report to its list of offerings. Presently, there is no cure for PSP and the effectiveness of prescribed generic medications and non-drug therapies to improve the quality of life in patients, is limited. The high unmet patient need and rising caregiver burden has inspired several players to focus their efforts on the development of therapies to control the progression of PSP or manage its symptoms. Consequently, multiple orphan designated drugs, currently in phase II of development, are anticipated to enter the market in the next 3-6 years. To order this 100+ page report, which features 70+ figures, please visit https://www.rootsanalysis.com/reports/progressive-supranuclear-palsy-market.html Key Market Insights
Medicine
Fitness+ 4 interests
Comment
steffanjoe101

Fc Protein and Glyco-engineered Antibodies Market

Roots Analysis has announced the addition of Fc Protein and Glyco-engineered Antibodies Market report to its list of offerings. Overview - Antibodies, also known as immunoglobulins, are Y-shaped glycoproteins that are produced by the immune system in response to foreign molecules (antigens) that enter the body.[1] The term antigen refers to any substance that is capable of inducing an immune response; examples include viruses, fungi, bacteria, proteins on the surface of cells, and non-living substances, such as toxins, chemicals and foreign particles. Once developed, these antibodies can protect an individual from getting affected after re-infection by a certain pathogen. To request a sample copy / brochure of this report, please visit this – https://www.rootsanalysis.com/reports/fc-protein-engineered-and-glycoengineered-antibodies-market/request-sample.html The Fc region of an antibody interacts with the Fc receptors and a few proteins of the complement system enabling the antibodies to activate the immune system. Advances in biotechnology have enabled researchers to alter the above-mentioned functions of the Fc region of an antibody in order to direct specific functions for use in various applications. For instance, the ADCC mechanism can be enhanced to improve antibody-mediated tumor cell killing. This can be achieved by increasing the binding strength between the Fc region of the antibody and the FcγR. It is possible to achieve such modifications through the introduction of site directed mutations in the contact residues or through the ablation of fucosylation of the Fc region. This research on the interaction between Fc region and Fc receptors has paved a new potential for the design of next generation therapeutic antibodies. Activation of phagocytosis, also called ADCP, is the most common function of the Fc receptors, along with ADCC and CDC.
Medicine
Fitness+ 4 interests
Comment
steffanjoe101

The Gene Editing beyond CRISPR Market, By Roots Analysis

With the approval of HUMULIN®, the first genetically modified drug, scientific community has made significant progress in developing gene edited therapies based on programmable nucleases, such as ZFNs, TALENs, EMNs and CRISPR London Roots Analysis has announced the addition of “Gene-Editing Beyond CRISPR: Focus on ZFN, TALENs and Meganucleases Market, 2021-2035” report to its list of offerings. The ability of gene editing solutions to directly target and modify genomic sequences has greatly expedited the progress of gene editing therapies into clinical stages. The clinical trials data of ZFNs, TALENs and meganucleases based therapies demonstrate their potential in the treatment of various diseases, including infectious diseases and oncological disorders. In addition, several product candidates are being evaluated in discovery and preclinical stages of development for hematological disorders, genetic disorders and neurological disorders. To order this 150+ page report, which features 100+ figures and 5+ tables, please visit https://www.rootsanalysis.com/reports/gene-editing-market.html
Medicine
Fitness+ 4 interests
Comment
steffanjoe101

The Alzheimer’s Disease Market (2nd edition), By Roots Analysis

The recent approval of Aduhelm™, an amyloid beta-directed antibody has led to players seeking approval for similar therapies; various interventions are being evaluated for the treatment / management of the inherently complex neurodegenerative disease Roots Analysis has announced the addition of “Alzheimer's Disease Market (2nd Edition), 2021-2031” report to its list of offerings. Limited treatment options and unmet needs are the key drivers of research activity in this domain. Several industry and non-industry players are presently engaged in developing various types of disease modifying interventions and drug / therapy candidates that offer symptomatic relief. Moreover, multiple venture capital firms and other strategic investors have been supporting the research related initiatives of various start-ups. Driven by a rich development pipeline and the efforts of various stakeholders, the market is anticipated to grow at a significant pace in the coming future. To order this 150+ page report, which features 90+ figures, please visit https://www.rootsanalysis.com/reports/view_document/alzheimers-disease-market/247.html Key Market Insights
Medicine
Fitness+ 4 interests
Comment
steffanjoe101

The Fc Fusion Therapeutics Market by Target Indications.

Since the approval of Enbrel® in 1998 for the treatment of rheumatoid arthritis, Fc fusion therapies have evolved into a prominent class of therapeutics; currently, several therapies are being developed for a variety of disease indications London Roots Analysis has announced the addition of “Fc Fusion Therapeutics Market, 2021-2030” report to its list of offerings. With 13 drugs approved in the European Union and the US, Fc fusion therapeutics are considered to be one of the most successful classes of IgG-based products. The success of these biopharmaceutical products can be attributed to their diverse biological and pharmacological properties, including an extended serum half-life, enhanced Fc mediated effector functions, easy expression, increased stability and aggregation resistance, modulated immunogenicity and improved safety profiles, for the treatment of a wide range of disease indications To order this 130+ page report, which features 95+ figures and 140+ tables, please visit https://www.rootsanalysis.com/reports/fc-fusion-therapeutics-market.html Key Market Insights
Medicine
Fitness+ 4 interests
Comment
steffanjoe101

The CD47 Targeting Therapeutics Market by Target Disease Indication.

Upon realizing the potential of this novel target, industry stakeholders have initiated several R&D efforts focused on exploiting the use of CD47 as an effective biomarker for the diagnosis and treatment purposes. Roots Analysis has announced the addition of “CD-47 Targeting Therapeutics Market, 2021-2035” report to its list of offerings. In recent years, the focus of the research community has shifted towards the development of novel treatment modalities, such as T- cell immunotherapies, that exhibit high efficacy. CD-47, owing to its increased expression on the surface of cancer cells, has emerged as a cancer immune checkpoint biomarker. To order this 190+ page report, which features 142+ figures, please visit https://www.rootsanalysis.com/reports/cd-47-targeting-therapeutics-market.html Key Market Insights Over 75 CD-47 drug candidates are under various phases of development
Medicine
Fitness+ 4 interests
Comment
steffanjoe101

Gene Editing beyond CRISPR Market: Focus on Zinc Finger Nucleases (ZFNs)

With the approval of HUMULIN®, the first genetically modified drug, scientific community has made significant progress in developing gene edited therapies based on programmable nucleases, such as ZFNs, TALENs, EMNs and CRISPR London Roots Analysis has announced the addition of “Gene-Editing Beyond CRISPR: Focus on ZFN, TALENs and Meganucleases Market, 2021-2035” report to its list of offerings. The ability of gene editing solutions to directly target and modify genomic sequences has greatly expedited the progress of gene editing therapies into clinical stages. The clinical trials data of ZFNs, TALENs and meganucleases based therapies demonstrate their potential in the treatment of various diseases, including infectious diseases and oncological disorders. In addition, several product candidates are being evaluated in discovery and preclinical stages of development for hematological disorders, genetic disorders and neurological disorders. To order this 150+ page report, which features 100+ figures and 5+ tables, please visit https://www.rootsanalysis.com/reports/gene-editing-market.html
Medicine
Fitness+ 4 interests
Comment
steffanjoe101

Regulatory T-Cell Therapies (Tregs) Market

Treg based therapies have become a research hotspot in the field of immunotherapy due to their ability to prevent / delay graft rejection and control autoimmune responses generated post adoptive transfer in vivo Roots Analysis has announced the addition of “Regulatory T-Cell (Tregs) Therapies Market, 2021 – 2035” report to its list of offerings. The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes: § A detailed assessment of the current market landscape of drug developers engaged in the development of regulatory T-cell therapies. § A detailed analysis of more than 180+ completed, ongoing and planned clinical studies of regulatory T-cell therapies. § Detailed profiles of developers of regulatory T-cell therapies (shortlisted on the basis of the number of pipeline products).
Medicine
Fitness+ 4 interests
Comment